Business context and reporting period
Benchmark Electronics, Inc. filed an annual Form 10-K for the fiscal year ended December 31, 2023, not a standalone fourth-quarter report. The company provides electronics manufacturing, precision technology, design, engineering and related services to OEMs in complex industrials, aerospace and defense (A&D), medical, semiconductor capital equipment (semi-cap), advanced computing and next-generation communications markets.
Financial performance
| Metric | 2023 | 2022 |
|---|---|---|
| Sales | $2,839.0 million | $2,886.3 million |
| Gross profit / margin | $271.1 million / 9.5% | $255.2 million / 8.8% |
| Operating income / margin | $109.7 million / 3.9% | $90.1 million / 3.1% |
| Net income | $64.3 million | $68.2 million |
| Diluted EPS | $1.79 | $1.91 |
| Operating cash flow | $174.3 million | $(177.5) million |
| Capital expenditures: property, plant and equipment | $73.5 million | $43.4 million |
Sales declined 2%, while gross profit rose 6% and operating income rose 22%. Management attributed the margin improvement to revenue mix, operational efficiencies, cost reduction actions and lower SG&A. Net income fell 6%, principally amid higher interest expense and less favorable other income/expense. Interest expense increased to $31.9 million from $12.9 million; the 2023 effective tax rate was 20.8%, versus 19.1%.
Liquidity, debt and capital allocation
At year-end, cash, cash equivalents and restricted cash totaled $283.2 million, including $5.8 million of restricted cash; $269.6 million was held outside the United States. Total debt, excluding unamortized issuance costs and finance leases, was $332.1 million, comprising $127.1 million under the term loan and $205.0 million under the revolving facility. The company reported $340.6 million available under the facility and compliance with its debt covenants. Working capital was $0.9 billion. Management stated that cash, operating cash generation and borrowing availability should meet liquidity needs for the next 12 months.
Operating cash flow improved substantially from 2022, supported in part by decreases in accounts receivable and inventory; the decrease in accounts payable partially offset those sources. The company paid $23.5 million in dividends in 2023, did not repurchase shares, and had $154.6 million remaining under its repurchase authorization. Planned 2024 capital expenditures are approximately $60–$70 million.
Material changes and management commentary
- Semi-cap sales fell 11% to $646.3 million and medical sales fell 6% to $556.6 million, reflecting lower customer demand and market softness.
- A&D sales rose 4% to $361.5 million, supported by defense and commercial aerospace demand and improved supply availability. Advanced computing increased 9% and next-generation communications increased 6%.
- Regional sales shifted: Americas increased 9%, Asia decreased 16%, and Europe increased 6%. International operations accounted for 58% of sales, compared with 61% in 2022.
- Restructuring charges and other costs totaled $8.4 million in 2023, including $7.3 million of restructuring charges and $1.1 million of asset impairment. Moorpark, California operations ceased in March 2023, with restructuring substantially completed by year-end.
- Component constraints generally eased, but shortages and limited capacity for some older semiconductor technologies remained a potential constraint. Management cited inflation, interest rates, geopolitical events and economic uncertainty as continuing sources of risk.
Outlook, risks and contingencies
The filing text provided does not include a clear quantified FY2024 revenue or earnings forecast. It does state that expected 2024 capital expenditures are $60–$70 million and that management expects available liquidity to cover at least the next 12 months. The board intends to continue quarterly dividends, but payments are not guaranteed and remain subject to financial, contractual and other conditions.
Key risks include concentrated customers and unpredictable order schedules; the ten largest customers generated 52% of 2023 sales, and Applied Materials represented 12%. Other material exposures include component availability and pricing, inventory obsolescence, manufacturing capacity utilization, international operations and currency movements, variable-rate debt, cybersecurity, regulatory and product-quality requirements, and loss or expiration of foreign tax incentives. The company had $192.1 million of goodwill and reported no impairment following its 2023 qualitative assessment. Management said ordinary-course legal matters were not expected to materially affect financial position or results.
Important facts for investors to verify
- Check subsequent results and guidance for recovery or further weakness in semi-cap and medical demand, and execution of growth programs in A&D, advanced computing and communications.
- Monitor cash conversion and inventory exposure, including the extent to which customer forecasts, reimbursement provisions and advance payments protect against cancellations or obsolete inventory.
- Track debt, borrowing costs, covenant headroom and the use of the revolving facility; the company’s interest-rate swap fixed the rate on $127.1 million of notional debt at 4.039%.
- Verify whether Malaysia and China tax incentives are renewed or replaced. China incentives expired at year-end 2023; Malaysia’s had expired in 2021, and applications were pending.
- Consider the concentration of cash held abroad, customer concentration, and the company’s ability to maintain dividends while funding planned capital spending.
- The independent auditor issued an unqualified opinion on the financial statements and internal control over financial reporting; management also concluded controls were effective as of December 31, 2023.